158 related articles for article (PubMed ID: 1533174)
1. Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.
Panella TJ; Smith DC; Schold SC; Rogers MP; Winer EP; Fine RL; Crawford J; Herndon JE; Trump DL
Cancer Res; 1992 May; 52(9):2456-9. PubMed ID: 1533174
[TBL] [Abstract][Full Text] [Related]
2. Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase.
Smith DC; Gerson SL; Liu L; Donnelly S; Day R; Trump DL; Kirkwood JM
Clin Cancer Res; 1996 Jul; 2(7):1129-34. PubMed ID: 9816278
[TBL] [Abstract][Full Text] [Related]
3. Modulation of human lymphocyte O6-alkylguanine-DNA alkyltransferase by streptozotocin in vivo.
Gerson SL
Cancer Res; 1989 Jun; 49(11):3134-8. PubMed ID: 2524250
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme.
Friedman HS; Dolan ME; Moschel RC; Pegg AE; Felker GM; Rich J; Bigner DD; Schold SC
J Natl Cancer Inst; 1992 Dec; 84(24):1926-31. PubMed ID: 1334154
[TBL] [Abstract][Full Text] [Related]
5. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.
Hansen RJ; Nagasubramanian R; Delaney SM; Cherian MM; Lin S; Kogan SC; Dolan ME
J Pharmacol Exp Ther; 2005 Dec; 315(3):1247-55. PubMed ID: 16126841
[TBL] [Abstract][Full Text] [Related]
6. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
Marathi UK; Dolan ME; Erickson LC
Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784
[TBL] [Abstract][Full Text] [Related]
7. Modulation of O6-alkylguanine alkyltransferase-directed DNA repair in metastatic colon cancers.
Willson JK; Haaga JR; Trey JE; Stellato TA; Gordon NH; Gerson SL
J Clin Oncol; 1995 Sep; 13(9):2301-8. PubMed ID: 7666087
[TBL] [Abstract][Full Text] [Related]
8. Comparisons between sensitive and resistant human tumor cell lines regarding effects of polyamine depletion on chloroethylnitrosourea efficacy.
Seidenfeld J; Sprague WS
Cancer Res; 1990 Feb; 50(3):521-6. PubMed ID: 2137022
[TBL] [Abstract][Full Text] [Related]
9. [Effect of pretreatment with N-methyl-N-nitrosourea or streptozotocin on the cytotoxicity and the induction of sister chromatid exchanges in human and rodent brain tumor cells treated with chloroethylnitrosourea].
Tokuda K
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):462-74. PubMed ID: 1427592
[TBL] [Abstract][Full Text] [Related]
10. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU.
Schold SC; Kokkinakis DM; Rudy JL; Moschel RC; Pegg AE
Cancer Res; 1996 May; 56(9):2076-81. PubMed ID: 8616853
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair.
Souliotis VL; Kaila S; Boussiotis VA; Pangalis GA; Kyrtopoulos SA
Cancer Res; 1990 May; 50(9):2759-64. PubMed ID: 2328502
[TBL] [Abstract][Full Text] [Related]
12. N-Methyl-N-nitrosourea potentiation of cytogenetic damage induced by 1,3-bis(2-chloroethyl)-1-nitrosourea in normal human lymphocytes.
Wiencke JK; Bodell WJ
Cancer Res; 1985 Oct; 45(10):4798-803. PubMed ID: 4027969
[TBL] [Abstract][Full Text] [Related]
13. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
[TBL] [Abstract][Full Text] [Related]
14. The role of O6-alkylguanine DNA alkyltransferase in limiting nitrosourea-induced sister chromatid exchanges in proliferating human lymphocytes.
Trey JE; Gerson SL
Cancer Res; 1989 Apr; 49(8):1899-903. PubMed ID: 2702633
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of streptozocin- and carmustine-sequenced administration in patients with advanced cancer.
Micetich KC; Futscher B; Koch D; Fisher RI; Erickson LC
J Natl Cancer Inst; 1992 Feb; 84(4):256-60. PubMed ID: 1531148
[TBL] [Abstract][Full Text] [Related]
16. Effects of streptozotocin/bis-chloroethylnitrosourea combination therapy on O6-methylguanine DNA methyltransferase activity and mRNA levels in HT-29 cells in vitro.
Pieper RO; Futscher BW; Dong Q; Erickson LC
Cancer Res; 1991 Mar; 51(6):1581-5. PubMed ID: 1825618
[TBL] [Abstract][Full Text] [Related]
17. Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Kurpad SN; Dolan ME; McLendon RE; Archer GE; Moschel RC; Pegg AE; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 1997; 39(4):307-16. PubMed ID: 9025771
[TBL] [Abstract][Full Text] [Related]
18. Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro.
Marathi UK; Kroes RA; Dolan ME; Erickson LC
Cancer Res; 1993 Sep; 53(18):4281-6. PubMed ID: 8364924
[TBL] [Abstract][Full Text] [Related]
19. Tumour levels of O6-alkylguanine-DNA-alkyltransferase and sensitivity to BCNU of human xenografts.
Tagliabue G; Citti L; Massazza G; Damia G; Giavazzi R; D'Incalci M
Anticancer Res; 1992; 12(6B):2123-5. PubMed ID: 1295458
[TBL] [Abstract][Full Text] [Related]
20. Modulation of O6-alkylguanine-DNA alkyltransferase in rats following intravenous administration of O6-methylguanine.
Dexter EU; Yamashita TS; Donovan C; Gerson SL
Cancer Res; 1989 Jul; 49(13):3520-4. PubMed ID: 2731174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
